Author

Livius Penter

Observed names: L Penter, Penter L., Penter Livius, Penter, Livius

Institutions: German Cancer Research Center, Humboldt-Universität zu Berlin, Dana-Farber Cancer Institute, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Deutsches Konsortium für Translationale Krebsforschung, Freie Universität Berlin, Charité - Universitätsmedizin Berlin

Observed institutions: Broad Institute, Harvard University, German Cancer Research Center, Humboldt-Universität zu Berlin, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Deutsches Konsortium für Translationale Krebsforschung, Stiftung Charité, Massachusetts Institute of Technology, Freie Universität Berlin, Charité - Universitätsmedizin Berlin

ORCID: 0000-0002-9060-0207

Observed ORCID: 0000-0002-9060-0207

OpenAlex ID: A5043167176

Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)

2019 · Andrea Cossarizza, Hyun‐Dong Chang, et al. · European Journal of Immunology · 979

PDF

Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey

2015 · R Zeiser, A Burchert, et al. · Leukemia · 539

Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti–PD-1 in head and neck cancer

2023 · Giacomo Oliveira, Ann Marie Egloff, et al. · Science Immunology · 119

PDF

Longitudinal Single-Cell Dynamics of Chromatin Accessibility and Mitochondrial Mutations in Chronic Lymphocytic Leukemia Mirror Disease History

2021 · Livius Penter, Satyen H. Gohil, et al. · Cancer Discovery · 63

Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease

2023 · Livius Penter, Yang Liu, et al. · Blood · 54

Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings

2022 · Jacqueline S. Garcia, Yael Flamand, et al. · Blood · 53

Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation

2021 · Livius Penter, Yi Zhang, et al. · Blood · 42

PDF

Integrative genotyping of cancer and immune phenotypes by long-read sequencing

2024 · Livius Penter, Mehdi Borji, et al. · Nature Communications · 40

PDF

Improved T-cell Immunity Following Neoadjuvant Chemotherapy in Ovarian Cancer

2022 · Min Liu, Nabihah Tayob, et al. · Clinical Cancer Research · 38

PDF

First-in-human evaluation of memory-like NK cells with an IL-15 super-agonist and CTLA-4 blockade in advanced head and neck cancer

2025 · Roman M. Shapiro, Michal Sheffer, et al. · Journal of Hematology & Oncology · 37

PDF

Coordinated immune networks in leukemia bone marrow microenvironments distinguish response to cellular therapy

2025 · Katie Maurer, Cameron Y. Park, et al. · Science Immunology · 34

FACS single cell index sorting is highly reliable and determines immune phenotypes of clonally expanded T cells

2018 · Livius Penter, Kerstin Dietze, et al. · European Journal of Immunology · 33

PDF

Localization-associated immune phenotypes of clonally expanded tumor-infiltrating T cells and distribution of their target antigens in rectal cancer

2019 · Livius Penter, Kerstin Dietze, et al. · OncoImmunology · 32

PDF

In Vivo Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities

2022 · Elisa ten Hacken, Tomasz Sewastianik, et al. · Blood Cancer Discovery · 29

Clonal Expansion and Interrelatedness of Distinct B-Lineage Compartments in Multiple Myeloma Bone Marrow

2017 · Leo Hansmann, Arnold Han, et al. · Cancer Immunology Research · 27

A rapid screening system evaluates novel inhibitors of DNA methylation and suggests F-box proteins as potential therapeutic targets for high-risk neuroblastoma

2015 · Livius Penter, Bert Maier, et al. · Targeted Oncology · 23

A multidimensional analysis reveals distinct immune phenotypes and the composition of immune aggregates in pediatric acute myeloid leukemia

2024 · Joost B. Koedijk, Inge van der Werf, et al. · Leukemia · 21

Systematic identification of minor histocompatibility antigens predicts outcomes of allogeneic hematopoietic cell transplantation

2024 · Nicoletta Cieri, Nidhi Hookeri, et al. · Nature Biotechnology · 20

Oncogene-induced TIM-3 ligand expression dictates susceptibility to anti–TIM-3 therapy in mice

2024 · Nana Talvard-Balland, Lukas M. Braun, et al. · Journal of Clinical Investigation · 20

Natural Barcodes for Longitudinal Single Cell Tracking of Leukemic and Immune Cell Dynamics

2022 · Livius Penter, Satyen H. Gohil, et al. · Frontiers in Immunology · 20

PDF

Mitochondrial DNA Mutations as Natural Barcodes for Lineage Tracing of Murine Tumor Models

2022 · Livius Penter, Elisa ten Hacken, et al. · Cancer Research · 17

PDF

Rapid single-cell identification of Epstein–Barr virus-specific T-cell receptors for cellular therapy

2022 · María Fernanda Lammoglia Cobo, Carlotta Welters, et al. · Cytotherapy · 17

Personal tumor antigens in blood malignancies: genomics-directed identification and targeting

2020 · Livius Penter, Catherine J. Wu · Journal of Clinical Investigation · 17

PDF

Sustained HIV-1 remission after heterozygous CCR5Δ32 stem cell transplantation

2025 · Christian Gaebler, Samad Kor, et al. · Nature · 16

Immune Phenotypes and Target Antigens of Clonally Expanded Bone Marrow T Cells in Treatment-Naïve Multiple Myeloma

2022 · Carlotta Welters, María Fernanda Lammoglia Cobo, et al. · Cancer Immunology Research · 16

PDF

Works count: 255

Citation count: 2,462

H-index: 20

I10-index: 33